Hansen Trevor, Olsen Keith, White Kevin, Keller Jesse
School of Medicine, Oregon Health and Science University, Portland, OR.
Department of Dermatology, Oregon Health and Science University, Portland, OR.
Am J Dermatopathol. 2018 Feb;40(2):e25-e27. doi: 10.1097/DAD.0000000000000950.
Cutaneous complications secondary to transcatheter arterial chemoembolization (TACE) are exceptionally rare and may occur because of nontarget embolization of terminal vessels supplying the skin. We present a patient who developed painful retiform purpura on the right flank shortly after TACE for treatment of hepatocellular carcinoma. Biopsy revealed intravascular tan to yellow amorphous spherical structures within the dermis, confirming the presence of foreign material within these vessels. The authors review the literature and discuss previous cases of skin lesions manifesting after TACE, as well as potential factors influencing the probability of cutaneous complications. Histopathologic findings described in similar cases are presented. Prophylactic measures and attempted treatments to reduce likelihood of long-term injury are also reviewed. An awareness that cutaneous injury is a rare, but potential complication of transcatheter arterial embolization, as well as an understanding of management options is important for any provider using this procedure.
经导管动脉化疗栓塞术(TACE)继发的皮肤并发症极为罕见,可能是由于供应皮肤的终末血管发生非靶性栓塞所致。我们报告一例在接受TACE治疗肝细胞癌后不久,右侧胁腹出现疼痛性网状紫癜的患者。活检显示真皮内血管内有棕褐色至黄色的无定形球形结构,证实这些血管内存在异物。作者回顾了文献并讨论了TACE后出现皮肤病变的既往病例,以及影响皮肤并发症发生概率的潜在因素。还介绍了类似病例中描述的组织病理学发现。也回顾了预防措施和为降低长期损伤可能性而尝试的治疗方法。认识到皮肤损伤是经导管动脉栓塞术一种罕见但潜在的并发症,以及了解管理选项对于任何使用该 procedure的医疗人员来说都很重要。 (注:原文中“this procedure”未明确具体是什么procedure,译文保留原文表述)